PL1817065T3 - Roztwory wiskoelastyczne zawierające hialuronian sodu i hydroksypropylometylocelulozę - Google Patents

Roztwory wiskoelastyczne zawierające hialuronian sodu i hydroksypropylometylocelulozę

Info

Publication number: PL1817065T3
Authority: PL; Poland
Prior art keywords: sodium hyaluronate; preparation; hydroxypropylmethyl; cellulose; solutions containing
Prior art date: 2004-11-30

Application number

PL05818937T

Other languages

English (en)

Inventor

Pierre Lebreton

Original Assignee

Valeant Spolka Z Ograniczona Odpowiedzialnoscia Spolka Jawna

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-11-30

Filing date

2005-11-28

Publication date

2011-09-30

2005-11-28 Application filed by Valeant Spolka Z Ograniczona Odpowiedzialnoscia Spolka Jawna filed Critical Valeant Spolka Z Ograniczona Odpowiedzialnoscia Spolka Jawna

2011-09-30 Publication of PL1817065T3 publication Critical patent/PL1817065T3/pl

Links

229920002385 Sodium hyaluronate Polymers 0.000 title abstract 3
239000001866 hydroxypropyl methyl cellulose Substances 0.000 title abstract 3
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 title abstract 3
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 title abstract 3
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 title abstract 3
229940010747 sodium hyaluronate Drugs 0.000 title abstract 3
YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 title abstract 3
239000008154 viscoelastic solution Substances 0.000 title 1
239000007943 implant Substances 0.000 abstract 2
239000007864 aqueous solution Substances 0.000 abstract 1
230000036571 hydration Effects 0.000 abstract 1
238000006703 hydration reaction Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
238000001356 surgical procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/041—Mixtures of macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/043—Mixtures of macromolecular materials

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Surgery (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Materials For Medical Uses (AREA)

PL05818937T 2004-11-30 2005-11-28 Roztwory wiskoelastyczne zawierające hialuronian sodu i hydroksypropylometylocelulozę PL1817065T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0412662A FR2878444B1 (fr)	2004-11-30	2004-11-30	Solutions viscoelastiques renfermant du hyaluronate de sodiu et de l'hydroxypropylmethylcellulose, preparation et utilisations
EP05818937A EP1817065B1 (fr)	2004-11-30	2005-11-28	Solutions viscoelastiques renfermant du hyaluronate de sodium et de l'hydroxypropylmethylcellulose
PCT/FR2005/050996 WO2006059029A2 (fr)	2004-11-30	2005-11-28	Solutions viscoelastiques renfermant du hyaluronate de sodium et de l'hydroxypropylmethyl- cellulose, preparation et utilisations

Publications (1)

Publication Number	Publication Date
PL1817065T3 true PL1817065T3 (pl)	2011-09-30

Family

ID=34952867

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05818937T PL1817065T3 (pl)	2004-11-30	2005-11-28	Roztwory wiskoelastyczne zawierające hialuronian sodu i hydroksypropylometylocelulozę

Country Status (11)

Country	Link
US (1)	US20080089918A1 (pl)
EP (1)	EP1817065B1 (pl)
JP (1)	JP2008521464A (pl)
AT (1)	ATE499121T1 (pl)
CA (1)	CA2589397C (pl)
DE (1)	DE602005026555D1 (pl)
DK (1)	DK1817065T3 (pl)
ES (1)	ES2364355T3 (pl)
FR (1)	FR2878444B1 (pl)
PL (1)	PL1817065T3 (pl)
WO (1)	WO2006059029A2 (pl)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2861734B1 (fr)	2003-04-10	2006-04-14	Corneal Ind	Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
EP2152743A2 (en) *	2007-05-23	2010-02-17	Allergan, Inc.	Cross-linked collagen and uses thereof
US8318695B2 (en) *	2007-07-30	2012-11-27	Allergan, Inc.	Tunably crosslinked polysaccharide compositions
US20120071437A1 (en)	2007-07-30	2012-03-22	Allergan, Inc.	Tunable crosslinked polysaccharide compositions
US8697044B2 (en)	2007-10-09	2014-04-15	Allergan, Inc.	Crossed-linked hyaluronic acid and collagen and uses thereof
EP2818184B1 (en)	2007-11-16	2018-10-31	Allergan, Inc.	Compositions and methods for treating Purpura
US8394784B2 (en) *	2007-11-30	2013-03-12	Allergan, Inc.	Polysaccharide gel formulation having multi-stage bioactive agent delivery
US20090143348A1 (en) *	2007-11-30	2009-06-04	Ahmet Tezel	Polysaccharide gel compositions and methods for sustained delivery of drugs
US8394782B2 (en)	2007-11-30	2013-03-12	Allergan, Inc.	Polysaccharide gel formulation having increased longevity
US8357795B2 (en)	2008-08-04	2013-01-22	Allergan, Inc.	Hyaluronic acid-based gels including lidocaine
WO2010028025A1 (en)	2008-09-02	2010-03-11	Gurtner Geoffrey C	Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
US20110171310A1 (en)	2010-01-13	2011-07-14	Allergan Industrie, Sas	Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use
US20110172180A1 (en)	2010-01-13	2011-07-14	Allergan Industrie. Sas	Heat stable hyaluronic acid compositions for dermatological use
US20110171286A1 (en) *	2010-01-13	2011-07-14	Allergan, Inc.	Hyaluronic acid compositions for dermatological use
US9114188B2 (en)	2010-01-13	2015-08-25	Allergan, Industrie, S.A.S.	Stable hydrogel compositions including additives
US20110171311A1 (en) *	2010-01-13	2011-07-14	Allergan Industrie, Sas	Stable hydrogel compositions including additives
EP2544652A2 (en)	2010-03-12	2013-01-16	Allergan Industrie SAS	A fluid composition comprising a hyaluronan polymer and mannitol for improving skin condition.
EP3520827B1 (en)	2010-03-22	2022-05-25	Allergan, Inc.	Cross-linked hydrogels for soft tissue augmentation
US8697057B2 (en)	2010-08-19	2014-04-15	Allergan, Inc.	Compositions and soft tissue replacement methods
US8883139B2 (en)	2010-08-19	2014-11-11	Allergan Inc.	Compositions and soft tissue replacement methods
US9005605B2 (en)	2010-08-19	2015-04-14	Allergan, Inc.	Compositions and soft tissue replacement methods
US8889123B2 (en)	2010-08-19	2014-11-18	Allergan, Inc.	Compositions and soft tissue replacement methods
KR102111170B1 (ko)	2011-01-13	2020-05-15	알러간, 인코포레이티드	첨가제들을 포함하는 안정된 히드로겔 조성물들
AU2012217630A1 (en)	2011-02-17	2013-09-05	Allergan, Inc.	Compositions and improved soft tissue replacement methods
US9149422B2 (en)	2011-06-03	2015-10-06	Allergan, Inc.	Dermal filler compositions including antioxidants
US20130096081A1 (en)	2011-06-03	2013-04-18	Allergan, Inc.	Dermal filler compositions
US9408797B2 (en)	2011-06-03	2016-08-09	Allergan, Inc.	Dermal filler compositions for fine line treatment
US9393263B2 (en)	2011-06-03	2016-07-19	Allergan, Inc.	Dermal filler compositions including antioxidants
EP3590495A1 (en)	2011-08-25	2020-01-08	Allergan, Inc.	Dermal filler compositions including antioxidants
US9662422B2 (en)	2011-09-06	2017-05-30	Allergan, Inc.	Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en)	2011-09-06	2013-09-19	Allergan, Inc.	Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
KR20200116168A (ko)	2011-09-14	2020-10-08	알러간, 인코포레이티드	잔주름 치료를 위한 진피 필러 조성물
GB201118586D0 (en) *	2011-10-27	2011-12-07	Turzi Antoine	New A-PRP medical device, manufacturing machine and process
HUE050978T2 (hu)	2011-12-08	2021-01-28	Allergan Ind Sas	Dermális töltõkészítmények
JP6108500B2 (ja)	2012-07-18	2017-04-05	アラーガン・アンデュストリー・ソシエテ・パール・アクシオン・サンプリフィエＡｌｌｅｒｇａｎＩｎｄｕｓｔｒｉｅＳａｓ	ピルビン酸塩を含有するヒアルロン酸製剤
ES2791180T3 (es)	2012-10-02	2020-11-03	Allergan Inc	Hidrogeles de relleno dérmico con complejos de inclusión de vitamina A/ciclodextrina
WO2014055895A1 (en)	2012-10-05	2014-04-10	Allergan, Inc.	Injectable device and method for sculpting, augmenting or correcting facial features such as the chin
WO2014072831A2 (en) *	2012-11-02	2014-05-15	Cesacar Holding, S.L.	Fluorescence coloring for eye surgery
EP2928426A2 (en)	2012-12-07	2015-10-14	Cesacar Participacions, S.L.	Femto second multi shooting for eye surgery
JP2017509433A (ja)	2014-04-01	2017-04-06	クロックステクノロジーズインコーポレイテッドＫｌｏｘＴｅｃｈｎｏｌｏｇｉｅｓＩｎｃ．	組織充填剤組成物および使用方法
EP3200838B1 (en)	2014-09-30	2019-09-18	Allergan Industrie, SAS	Stable hydrogel compositions including additives
CN107427584A (zh)	2015-01-28	2017-12-01	阿勒根公司	关节脂肪垫制剂及其使用方法
WO2016128783A1 (en)	2015-02-09	2016-08-18	Allergan Industrie Sas	Compositions and methods for improving skin appearance
WO2016128550A1 (en)	2015-02-13	2016-08-18	Allergan Industrie, Sas	Implants for sculpting, augmenting or correcting facial features such as the chin
CN109890428B (zh)	2016-10-13	2022-06-10	阿勒根公司	用于真皮填充剂应用的凝聚层透明质素水凝胶
US12440835B2 (en)	2019-01-21	2025-10-14	Vias Partners, Llc	Methods, systems and apparatus for separating components of a biological sample
KR20220091580A (ko)	2019-10-31	2022-06-30	이클립스 메드코프 엘엘씨	샘플의 구성요소들을 분리하기 위한 시스템, 방법 및 장치

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5409904A (en) *	1984-11-13	1995-04-25	Alcon Laboratories, Inc.	Hyaluronic acid compositions and methods
JPS62122671A (ja) *	1985-11-23	1987-06-03	千寿製薬株式会社	眼内手術用高粘性液の製造法
WO1995007085A1 (en) *	1993-09-07	1995-03-16	Escalon Ophthalmics, Inc.	Surface active viscoelastic solutions for ocular use
AU2002360752A1 (en) *	2001-12-21	2003-07-30	Alcon, Inc.	Viscoelastics for ocular surgery

2004
- 2004-11-30 FR FR0412662A patent/FR2878444B1/fr not_active Expired - Fee Related
2005
- 2005-11-28 ES ES05818937T patent/ES2364355T3/es not_active Expired - Lifetime
- 2005-11-28 AT AT05818937T patent/ATE499121T1/de active
- 2005-11-28 EP EP05818937A patent/EP1817065B1/fr not_active Expired - Lifetime
- 2005-11-28 DK DK05818937.4T patent/DK1817065T3/da active
- 2005-11-28 DE DE602005026555T patent/DE602005026555D1/de not_active Expired - Lifetime
- 2005-11-28 PL PL05818937T patent/PL1817065T3/pl unknown
- 2005-11-28 WO PCT/FR2005/050996 patent/WO2006059029A2/fr not_active Ceased
- 2005-11-28 JP JP2007542074A patent/JP2008521464A/ja active Pending
- 2005-11-28 CA CA2589397A patent/CA2589397C/en not_active Expired - Lifetime
- 2005-11-28 US US11/791,603 patent/US20080089918A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2006059029A2 (fr)	2006-06-08
WO2006059029A3 (fr)	2006-08-31
ATE499121T1 (de)	2011-03-15
DK1817065T3 (da)	2011-06-14
US20080089918A1 (en)	2008-04-17
EP1817065A2 (fr)	2007-08-15
FR2878444B1 (fr)	2008-04-25
EP1817065B1 (fr)	2011-02-23
JP2008521464A (ja)	2008-06-26
CA2589397A1 (en)	2006-06-08
DE602005026555D1 (de)	2011-04-07
ES2364355T3 (es)	2011-08-31
CA2589397C (en)	2015-03-31
FR2878444A1 (fr)	2006-06-02

Publication	Publication Date	Title
PL1817065T3 (pl)	2011-09-30	Roztwory wiskoelastyczne zawierające hialuronian sodu i hydroksypropylometylocelulozę
WO2005082414A3 (en)	2006-06-29	Concomitant drugs of a sulfonamide and another therapeutic agent
ITRM20020596A0 (it)	2002-11-27	Protesi vascolare ad impianto con tecnica combinata, laparoscopica edendovascolare, per la cura degli aneurismi dell'aorta addominale, e co
CY1105120T1 (el)	2010-03-03	Η αντιμετωπιση αναπνευστικων νοσων
YU98503A (sh)	2006-05-25	Pulmonarno ordiniranje hemijski modifikovanog insulina
ATE328865T1 (de)	2006-06-15	Okklusionszusammensetzung umfassend ein poly(2- cyanoacrylat)-monomer
PT1401501E (pt)	2005-10-31	Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo
MXPA05003394A (es)	2005-10-05	Conjugados de polimero con antigenicidad disminuida, metodos de preparacion y usos de estos.
TN2010000019A1 (en)	2011-09-26	Solid preparation comprising alogliptin and metformin hydrochloride
GEP20084341B (en)	2008-03-25	Aminoheteroaryl compounds as protein kinase inhibitors
NO20024891L (no)	2002-12-05	Farmasöytiske sammensetninger
EP2261236A3 (en)	2011-09-14	Composition for proteasome inhibition
MX2007002189A (es)	2008-01-11	Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos.
WO2007139760A3 (en)	2008-10-23	Resorbable polymer compositions for use in medicine, dentistry, and surgery
YU37703A (sh)	2006-05-25	Pantoprazol preparat i pantoprazol injekcija osušeni putem zamrzavanja
TW200833370A (en)	2008-08-16	Pharmaceutical composition containing low substituted hydroxypropylcellulose
WO2004039248A3 (en)	2004-10-14	Repairing or replacing tissues or organs
MXPA03008215A (es)	2004-01-29	Inhibidores de integrina alfa v beta 6.
UA88463C2 (ru)	2009-10-26	Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
DK1715900T3 (da)	2010-05-25	Kompositstrukturer, som indeholder hyaluronsyre derivaterne deraf som nye knoglesubstitutter og -transplantater
SE0402762D0 (sv)	2004-11-11	Indazole sulphonamide derivatives
PT1185253E (pt)	2004-07-30	Forma de administracao oral para administracao de uma combinacao fixa de tramadol e diclofenac
DE502005010427D1 (de)	2010-12-02	Physiologisch aktive zusammensetzung gegen diabetes
IS7908A (is)	2005-06-23	Ný notkun dextransúlfats
EA200200853A1 (ru)	2003-02-27	Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака